Charles River Laboratories (CRL): Exploring Valuation After New Drug Discovery Collaborations Boost Innovation Prospects
Simply Wall St 02/11 07:47
Telsey Advisory Group Maintains Outperform on Target, Maintains $195 Price Target
Target Corporation -1.61%
Target Corporation TGT | 0.00 |
Telsey Advisory Group analyst Joseph Feldman maintains Target (NYSE:
TGT) with a Outperform and maintains $195 price target.
Recommend
Diversified Healthcare Trust (DHC): Valuation in Focus as Investors Await Q3 2025 Earnings and Mixed Analyst Views
Simply Wall St 02/11 08:29Trinity Industries (TRN): Revisiting Valuation After Strong Q3 Earnings and Upbeat Guidance
Simply Wall St 02/11 09:27A Look at Nu Holdings (NYSE:NU) Valuation as It Applies for U.S. National Bank License
Simply Wall St 02/11 10:32Sweetgreen (SG): Valuation in Focus as Investors Await Earnings and New Menu Launch
Simply Wall St 02/11 11:32UPDATE 1-OPEC+ set to agree another modest oil output increase, sources say
Reuters 02/11 12:12A16z Pauses Its TxO Fund for Underserved Founders After Five Years Amid Industrywide DEI Pullback: Report
Benzinga News 04/11 06:43Is Target a Bargain After 33% Stock Drop and Supply Chain Shakeup?
Simply Wall St 04/11 18:38
